GABRIELLA LEARY: Open Payments
NPI 1124740865 · SURFSIDE BEACH, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,365 in 61 payments from 17 companies in 2025. Trend: 2023 $701 · 2024 $699 · 2025 $1,365
Food & beverage: $1,365
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 18 | $301 |
| AstraZeneca Pharmaceuticals LP | 11 | $230 |
| Amgen Inc. | 5 | $194 |
| Boston Scientific Corporation | 1 | $140 |
| Novo Nordisk Inc | 5 | $119 |
| ABBVIE INC. | 6 | $108 |
| Dexcom, Inc. | 2 | $49 |
| Xeris Pharmaceuticals, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $35 |
| Daiichi Sankyo Inc. | 1 | $24 |
Products named: TRELEGY ELLIPTA, AIRSUPRA, REPATHA, WaveWriter Alpha Prime 16, SHINGRIX, Wegovy, VRAYLAR, Dexcom G6 Transmitter.
Industry payments across SC — which companies pay providers there.
